Published : Oct-2017
No. of Pages : 128
1 Table of Contents 2
1.1 List of Tables 5
1.2 List of Figures 8
2 Introduction 9
2.1 Electrophysiology Ablation Catheters Overview 9
3 Products under Development 10
3.1 Electrophysiology Ablation Catheters - Pipeline Products by Stage of Development 10
3.2 Electrophysiology Ablation Catheters - Pipeline Products by Segment 11
3.3 Electrophysiology Ablation Catheters - Pipeline Products by Territory 12
3.4 Electrophysiology Ablation Catheters - Pipeline Products by Regulatory Path 13
3.5 Electrophysiology Ablation Catheters - Pipeline Products by Estimated Approval Date 14
3.6 Electrophysiology Ablation Catheters - Ongoing Clinical Trials 15
4 Electrophysiology Ablation Catheters - Pipeline Products under Development by Companies 16
4.1 Electrophysiology Ablation Catheters Companies - Pipeline Products by Stage of Development 16
4.2 Electrophysiology Ablation Catheters - Pipeline Products by Stage of Development 18
5 Electrophysiology Ablation Catheters Companies and Product Overview 20
5.1 Ablacon Inc Company Overview 20
5.1.1 Ablacon Inc Pipeline Products & Ongoing Clinical Trials Overview 20
5.2 Advanced Cardiac Therapeutics, Inc. Company Overview 21
5.2.1 Advanced Cardiac Therapeutics, Inc. Pipeline Products & Ongoing Clinical Trials Overview 21
5.3 Apama Medical, Inc. Company Overview 22
5.3.1 Apama Medical, Inc. Pipeline Products & Ongoing Clinical Trials Overview 22
5.4 Biosense Webster Inc Company Overview 23
5.4.1 Biosense Webster Inc Pipeline Products & Ongoing Clinical Trials Overview 23
5.5 BioTex Inc Company Overview 27
5.5.1 BioTex Inc Pipeline Products & Ongoing Clinical Trials Overview 27
5.6 Boston Scientific Corp Company Overview 29
5.6.1 Boston Scientific Corp Pipeline Products & Ongoing Clinical Trials Overview 29
5.7 Cardima, Inc. (Inactive) Company Overview 36
5.7.1 Cardima, Inc. (Inactive) Pipeline Products & Ongoing Clinical Trials Overview 36
5.8 CardioFocus Inc Company Overview 38
5.8.1 CardioFocus Inc Pipeline Products & Ongoing Clinical Trials Overview 38
5.9 CardioNova Ltd Company Overview 39
5.9.1 CardioNova Ltd Pipeline Products & Ongoing Clinical Trials Overview 39
5.10 CathEffects LLC Company Overview 40
5.10.1 CathEffects LLC Pipeline Products & Ongoing Clinical Trials Overview 40
5.11 CathRx Ltd Company Overview 41
5.11.1 CathRx Ltd Pipeline Products & Ongoing Clinical Trials Overview 41
5.12 Columbia University Company Overview 44
5.12.1 Columbia University Pipeline Products & Ongoing Clinical Trials Overview 44
5.13 Cordis Corp Company Overview 45
5.13.1 Cordis Corp Pipeline Products & Ongoing Clinical Trials Overview 45
5.14 CryoTherapeutics Gmbh Company Overview 46
5.14.1 CryoTherapeutics Gmbh Pipeline Products & Ongoing Clinical Trials Overview 46
5.15 Epicardial Technologies Inc Company Overview 47
5.15.1 Epicardial Technologies Inc Pipeline Products & Ongoing Clinical Trials Overview 47
5.16 FocusStart LLC Company Overview 48
5.16.1 FocusStart LLC Pipeline Products & Ongoing Clinical Trials Overview 48
5.17 Interventional Imaging, Inc. Company Overview 49
5.17.1 Interventional Imaging, Inc. Pipeline Products & Ongoing Clinical Trials Overview 49
5.18 Iowa Approach Inc. Company Overview 50
5.18.1 Iowa Approach Inc. Pipeline Products & Ongoing Clinical Trials Overview 50
5.19 Maestro Heart SA Company Overview 53
5.19.1 Maestro Heart SA Pipeline Products & Ongoing Clinical Trials Overview 53
5.20 Mayo Clinic US Company Overview 54
5.20.1 Mayo Clinic US Pipeline Products & Ongoing Clinical Trials Overview 54
5.21 Medlumics SL Company Overview 55
5.21.1 Medlumics SL Pipeline Products & Ongoing Clinical Trials Overview 55
5.22 Medtronic plc Company Overview 56
5.22.1 Medtronic plc Pipeline Products & Ongoing Clinical Trials Overview 56
5.23 MedWaves Inc Company Overview 60
5.23.1 MedWaves Inc Pipeline Products & Ongoing Clinical Trials Overview 60
5.24 MicroPort Scientific Corp Company Overview 61
5.24.1 MicroPort Scientific Corp Pipeline Products & Ongoing Clinical Trials Overview 61
5.25 North Carolina State University Company Overview 63
5.25.1 North Carolina State University Pipeline Products & Ongoing Clinical Trials Overview 63
5.26 Northwestern University Company Overview 64
5.26.1 Northwestern University Pipeline Products & Ongoing Clinical Trials Overview 64
5.27 SCR, Inc. Company Overview 65
5.27.1 SCR, Inc. Pipeline Products & Ongoing Clinical Trials Overview 65
5.28 St. Jude Medical LLC Company Overview 66
5.28.1 St. Jude Medical LLC Pipeline Products & Ongoing Clinical Trials Overview 66
5.29 Stereotaxis Inc Company Overview 68
5.29.1 Stereotaxis Inc Pipeline Products & Ongoing Clinical Trials Overview 68
5.30 Strategic Polymer Sciences, Inc Company Overview 69
5.30.1 Strategic Polymer Sciences, Inc Pipeline Products & Ongoing Clinical Trials Overview 69
5.31 University of Michigan Company Overview 70
5.31.1 University of Michigan Pipeline Products & Ongoing Clinical Trials Overview 70
5.32 University of Rochester Company Overview 71
5.32.1 University of Rochester Pipeline Products & Ongoing Clinical Trials Overview 71
5.33 University of Texas Medical Branch at Galveston Company Overview 72
5.33.1 University of Texas Medical Branch at Galveston Pipeline Products & Ongoing Clinical Trials Overview 72
5.34 Vanderbilt University Company Overview 73
5.34.1 Vanderbilt University Pipeline Products & Ongoing Clinical Trials Overview 73
5.35 Vimecon GmbH Company Overview 74
5.35.1 Vimecon GmbH Pipeline Products & Ongoing Clinical Trials Overview 74
5.36 Vivonics, Inc. Company Overview 75
5.36.1 Vivonics, Inc. Pipeline Products & Ongoing Clinical Trials Overview 75
5.37 Voyage Medical (Inactive) Company Overview 76
5.37.1 Voyage Medical (Inactive) Pipeline Products & Ongoing Clinical Trials Overview 76
6 Electrophysiology Ablation Catheters- Recent Developments 77
6.1 Sep 11, 2017: MPSC Achieves Substantial Growth in 1H 2017 Net Profit Increases 272.4% YOY 77
6.2 Aug 22, 2017: Medtronic Reports First Quarter Financial Results 78
6.3 Aug 11, 2017: MPSC Issues Positive Profit Alert for 2017 1H Net Profit Expected to Increase 261% 81
6.4 Aug 10, 2017: Stereotaxis Reports Second Quarter 2017 Financial Results 81
6.5 Aug 01, 2017: FIRE AND ICE Trial Analysis Shows Medtronic Cryoballoon Reduces Healthcare System Costs and Utilization 82
6.6 Jul 27, 2017: Boston Scientific Announces Results for Second Quarter 2017 83
6.7 Jul 25, 2017: Catherine Estrampes appointed President & CEO of GE Healthcare Europe 85
6.8 Jul 24, 2017: MicroPort Attends EUROPACE-CARDIOSTIM 2017 86
6.9 Jul 11, 2017: Clinical Trial to Evaluate Medtronic Cryoablation as First-Line Treatment for Patients With Symptomatic Paroxysmal Atrial Fibrillation 86
6.10 Jul 07, 2017: MPSC New COO Glendy Wang on Board 87
6.11 Jun 27, 2017: Boston Scientific Outlines Strategy for Sustained Growth at 2017 Investor Day 87
6.12 Jun 12, 2017: Kieran Murphy Appointed CEO of GE Healthcare, Succeeding John Flannery 89
6.13 May 25, 2017: Medtronic Reports Fourth Quarter and Fiscal Year 2017 Financial Results 90
6.14 May 23, 2017: MicroPort EP Obtains Thailand FDA Approval for FireMagic 3D Irrigated Ablation Catheter 93
6.15 May 23, 2017: MicroPort EP Obtains Thailand FDA Approval for FireMagic Cardiac RF Ablation Catheter 93
6.16 May 09, 2017: Abbott Announces CE Mark for TactiCath Contact Force Ablation Catheter, Sensor Enabled 93
6.17 May 08, 2017: Stereotaxis Reports 2017 First Quarter Financial Results 95
6.18 Apr 27, 2017: Medtronic Expands Pain Therapies Portfolio with the Launch of OsteoCool RF Ablation System 96
6.19 Apr 27, 2017: Boston Scientific Announces Results For First Quarter 2017 96
6.20 Apr 23, 2017: Bard Announces First Quarter Results 97
6.21 Mar 30, 2017: Medtronic Initiates Global Trial Evaluating Cryoablation to Treat Persistent Atrial Fibrillation 98
6.22 Mar 30, 2017: MPSC Announces 2016 Annual Results 99
6.23 Mar 21, 2017: Texas Cardiac Arrhythmia Institute at St. David's Medical Center First in Texas and Among First in U.S. to Use FlexAbility Ablation Catheter, Sensor Enabled 100
6.24 Mar 10, 2017: FireMagic Cardiac RF Ablation Catheter Gains MFDS Approval 101
6.25 Mar 01, 2017: Abbott Announces FDA Approval Of Flexability Ablation Catheter, Sensor Enabled To Advance The Treatment Of Complex Cardiac Arrhythmias 102
6.26 Feb 21, 2017: Medtronic Reports Third Quarter Financial Results 102
6.27 Feb 16, 2017: FDA Approves Expanded Indication for Medtronic Freezor Xtra Cryoablation Catheter 105
6.28 Feb 15, 2017: Medtronic's OsteoCool RF Ablation System Receives Expanded Indication for Palliative Treatment of Metastatic Bone Tumors 106
6.29 Feb 06, 2017: Medtronic Awarded U.S. Department of Veterans Affairs National Contracts for Home Telehealth Technologies, with Three Other Vendors 107
6.30 Feb 06, 2017: Stereotaxis Announces Management Transition and 2016 Financial Results 107
6.31 Feb 02, 2017: Boston Scientific Announces Results For Fourth Quarter And Full Year Ended December 31, 2016 109
6.32 Jan 26, 2017: Bard Announces Fourth Quarter Results 110
6.33 Jan 19, 2017: CardioFocus Announces Initial Clinical Evaluation of Next-Generation HeartLight Excalibur Balloon Designed For the Treatment of Atrial Fibrillation 111
6.34 Nov 22, 2016: Medtronic Reports Second Quarter Financial Results 112
6.35 Nov 16, 2016: Medtronic Releases FY16 Integrated Performance Report 115
6.36 Nov 15, 2016: CEVA to work with Medtronic for distribution facility construction 115
6.37 Nov 07, 2016: Stereotaxis Reports 2016 Third Quarter Financial Results 116
6.38 Nov 01, 2016: GE Healthcare enhances single-use manufacturing capabilities with facility expansion and automation 118
6.39 Oct 26, 2016: Boston Scientific Announces Results For Third Quarter 2016 118
6.40 Oct 25, 2016: Bard Announces Third Quarter Results 120
6.41 Oct 19, 2016: FireMagic Cool Catheter Obtains CFDA Approval 120
6.42 Oct 19, 2016: St. Jude Medical Reports Third Quarter 2016 Results 121
6.43 Oct 10, 2016: Professor Ian Meredith To Join Boston Scientific As Executive Vice President And Global Chief Medical Officer 123
6.44 Sep 27, 2016: Stereotaxis Announces Recruitment of Highly Experienced Board Members 123
7 Appendix 125
7.1 Methodology 125
7.2 About GlobalData 128
7.3 Contact Us 128
7.4 Disclaimer 128
1.1 List of Tables
Table 1: Electrophysiology Ablation Catheters - Pipeline Products by Stage of Development 10
Table 2: Electrophysiology Ablation Catheters - Pipeline Products by Segment 11
Table 3: Electrophysiology Ablation Catheters - Pipeline Products by Territory 12
Table 4: Electrophysiology Ablation Catheters - Pipeline Products by Regulatory Path 13
Table 5: Electrophysiology Ablation Catheters - Pipeline Products by Estimated Approval Date 14
Table 6: Electrophysiology Ablation Catheters - Ongoing Clinical Trials 15
Table 7: Electrophysiology Ablation Catheters Companies - Pipeline Products by Stage of Development 16
Table 8: Electrophysiology Ablation Catheters - Pipeline Products by Stage of Development 18
Table 9: Ablacon Inc Pipeline Products & Ongoing Clinical Trials Overview 20
Table 10: Ablasense - Product Status 20
Table 11: Ablasense - Product Description 20
Table 12: Advanced Cardiac Therapeutics, Inc. Pipeline Products & Ongoing Clinical Trials Overview 21
Table 13: ACT Cardiac Ablation Catheter - Product Status 21
Table 14: ACT Cardiac Ablation Catheter - Product Description 21
Table 15: Apama Medical, Inc. Pipeline Products & Ongoing Clinical Trials Overview 22
Table 16: Apama Ablation Catheter - Product Status 22
Table 17: Apama Ablation Catheter - Product Description 22
Table 18: Biosense Webster Inc Pipeline Products & Ongoing Clinical Trials Overview 23
Table 19: CARTO SMARTTOUCH 5D Catheter - Product Status 23
Table 20: CARTO SMARTTOUCH 5D Catheter - Product Description 23
Table 21: Next Generation Ablation Catheter - Product Status 24
Table 22: Next Generation Ablation Catheter - Product Description 24
Table 23: Biosense Webster Inc - Ongoing Clinical Trials Overview 25
Table 24: CARTO SMARTTOUCH 5D Catheter - Clinical Study for Workflow and Acute Performance Evaluation of the Thermocool Smarttouch SF-5D System (The Thermocool Smarttouch SF-5D Catheter with Temperature Sensing Capabilities and Micro Electrodes and CARTO 3 V 6.0 Technology) in Treatment of Patie 26
Table 25: BioTex Inc Pipeline Products & Ongoing Clinical Trials Overview 27
Table 26: Cooled Tip Catheter - Product Status 27
Table 27: Cooled Tip Catheter - Product Description 27
Table 28: Water-cooled Catheter - Product Status 28
Table 29: Water-cooled Catheter - Product Description 28
Table 30: Boston Scientific Corp Pipeline Products & Ongoing Clinical Trials Overview 29
Table 31: Cryo Balloon Catheter - Product Status 29
Table 32: Cryo Balloon Catheter - Product Description 29
Table 33: DirectSense Rx Catheter - Product Status 30
Table 34: DirectSense Rx Catheter - Product Description 30
Table 35: Force Sensing Afib Catheter - Product Status 30
Table 36: Force Sensing Afib Catheter - Product Description 30
Table 37: IntellaNav MiFi OI AF Ablation Catheter - Product Status 31
Table 38: IntellaNav MiFi OI AF Ablation Catheter - Product Description 31
Table 39: Next Generation Blazer Catheter - Product Status 31
Table 40: Next Generation Blazer Catheter - Product Description 32
Table 41: Next Generation IntellaTip Catheter - Product Status 32
Table 42: Next Generation IntellaTip Catheter - Product Description 32
Table 43: Boston Scientific Corp - Ongoing Clinical Trials Overview 33
Table 44: Next Generation IntellaTip Catheter - Microfidelity (MIFI) Ablation Technology Versus Standard Ablation Catheter for Atrioventricular Nodal Ablation A Comparative Pilot Study of Time to Success 34
Table 45: IntellaNav MiFi OI AF Ablation Catheter - Electrical Coupling Information from the Rhythmia HDx Mapping System and Direct Sense Technology in the Treatment of Paroxysmal Atrial Fibrillation - A Non-randomized, Prospective Study 35
Table 46: Cardima, Inc. (Inactive) Pipeline Products & Ongoing Clinical Trials Overview 36
Table 47: CADENCE EPL - Product Status 36
Table 48: CADENCE EPL - Product Description 36
Table 49: EP Ablation System - Product Status 37
Table 50: EP Ablation System - Product Description 37
Table 51: CardioFocus Inc Pipeline Products & Ongoing Clinical Trials Overview 38
Table 52: HeartLight Excalibur Balloon - Product Status 38
Table 53: HeartLight Excalibur Balloon - Product Description 38
Table 54: CardioNova Ltd Pipeline Products & Ongoing Clinical Trials Overview 39
Table 55: Catheter To Treat Atrial Fibrillation - Product Status 39
Table 56: Catheter To Treat Atrial Fibrillation - Product Description 39
Table 57: CathEffects LLC Pipeline Products & Ongoing Clinical Trials Overview 40
Table 58: Desai VectorCathRF1 Mapping And Ablation Catheter - Product Status 40
Table 59: Desai VectorCathRF1 Mapping And Ablation Catheter - Product Description 40
Table 60: CathRx Ltd Pipeline Products & Ongoing Clinical Trials Overview 41
Table 61: CathRx 4mm Therapeutic Catheter - Product Status 41
Table 62: CathRx 4mm Therapeutic Catheter - Product Description 41
Table 63: CathRx 8mm Therapeutic Catheter - Product Status 42
Table 64: CathRx 8mm Therapeutic Catheter - Product Description 42
Table 65: Khelix Irrigated Ablation EP Catheter - Product Status 42
Table 66: Khelix Irrigated Ablation EP Catheter - Product Description 43
Table 67: Khelix Non-Irrigated Ablation EP Catheter - Product Status 43
Table 68: Khelix Non-Irrigated Ablation EP Catheter - Product Description 43
Table 69: Columbia University Pipeline Products & Ongoing Clinical Trials Overview 44
Table 70: Optically-Integrated RFA Catheter - Product Status 44
Table 71: Optically-Integrated RFA Catheter - Product Description 44
Table 72: Cordis Corp Pipeline Products & Ongoing Clinical Trials Overview 45
Table 73: EP Contact Force Sensing Catheter Enabled By CARTO 3 - Product Status 45
Table 74: EP Contact Force Sensing Catheter Enabled By CARTO 3 - Product Description 45
Table 75: CryoTherapeutics Gmbh Pipeline Products & Ongoing Clinical Trials Overview 46
Table 76: Cryotherapy System - Coronary Artery Disease - Product Status 46
Table 77: Cryotherapy System - Coronary Artery Disease - Product Description 46
Table 78: Epicardial Technologies Inc Pipeline Products & Ongoing Clinical Trials Overview 47
Table 79: Epicardial Access Device - Product Status 47
Table 80: Epicardial Access Device - Product Description 47
Table 81: FocusStart LLC Pipeline Products & Ongoing Clinical Trials Overview 48
Table 82: Anti-coagulum Cardiac Ablation Catheter - Product Status 48
Table 83: Anti-coagulum Cardiac Ablation Catheter - Product Description 48
Table 84: Interventional Imaging, Inc. Pipeline Products & Ongoing Clinical Trials Overview 49
Table 85: Atrial Fibrillation Catheter - Product Status 49
Table 86: Atrial Fibrillation Catheter - Product Description 49
Table 87: Iowa Approach Inc. Pipeline Products & Ongoing Clinical Trials Overview 50
Table 88: MaPP-CS - Product Status 50
Table 89: MaPP-CS - Product Description 50
Table 90: ROF-AC - Product Status 51
Table 91: ROF-AC - Product Description 51
Table 92: ROF-AS - Product Status 51
Table 93: ROF-AS - Product Description 52
Table 94: Maestro Heart SA Pipeline Products & Ongoing Clinical Trials Overview 53
Table 95: Maestro-AF Catheter System - Product Status 53
Table 96: Maestro-AF Catheter System - Product Description 53
Table 97: Mayo Clinic US Pipeline Products & Ongoing Clinical Trials Overview 54
Table 98: Pulmonary Vein Ablation Device - Product Status 54
Table 99: Pulmonary Vein Ablation Device - Product Description 54
Table 100: Medlumics SL Pipeline Products & Ongoing Clinical Trials Overview 55
Table 101: RF Ablation Catheter - Product Status 55
Table 102: RF Ablation Catheter - Product Description 55
Table 103: Medtronic plc Pipeline Products & Ongoing Clinical Trials Overview 56
Table 104: PVAC Gold - Product Status 56
Table 105: PVAC Gold - Product Description 57
Table 106: Medtronic plc - Ongoing Clinical Trials Overview 58
Table 107: PVAC Gold - Postmarket Evaluation of the Phased Radio Frequency Ablation System (GOLD AF Registry) 59
Table 108: PVAC Gold - PVAC GOLD Versus Irrigated RF Single Tip Catheter with Contact Force Ablation of the Pulmonary Veins for Treatment of Drug Refractory Symptomatic Paroxysmal and Persistent Atrial Fibrillation 59
Table 109: PVAC Gold - The Prospective, Multicenter Canadian Atrial Fibrillation PVAC Cohort Study 59
Table 110: MedWaves Inc Pipeline Products & Ongoing Clinical Trials Overview 60
Table 111: Arrhythmia Catheters - Product Status 60
Table 112: Arrhythmia Catheters - Product Description 60
Table 113: MicroPort Scientific Corp Pipeline Products & Ongoing Clinical Trials Overview 61
Table 114: Circular Ablation Catheter - Product Status 61
Table 115: Circular Ablation Catheter - Product Description 61
Table 116: Voyager Irrigated RF Ablation Catheter - Product Status 62
Table 117: Voyager Irrigated RF Ablation Catheter - Product Description 62
Table 118: North Carolina State University Pipeline Products & Ongoing Clinical Trials Overview 63
Table 119: Robotic Catheter - Product Status 63
Table 120: Robotic Catheter - Product Description 63
Table 121: Northwestern University Pipeline Products & Ongoing Clinical Trials Overview 64
Table 122: Cardiac Catheter - Product Status 64
Table 123: Cardiac Catheter - Product Description 64
Table 124: SCR, Inc. Pipeline Products & Ongoing Clinical Trials Overview 65
Table 125: Atrial Fibrillation Device - Product Status 65
Table 126: Atrial Fibrillation Device - Product Description 65
Table 127: St. Jude Medical LLC Pipeline Products & Ongoing Clinical Trials Overview 66
Table 128: All-in-one Catheter Ablation System - Product Status 66
Table 129: All-in-one Catheter Ablation System - Product Description 66
Table 130: TactiCath Contact Force Ablation Catheter - Sensor Enabled - Product Status 67
Table 131: TactiCath Contact Force Ablation Catheter - Sensor Enabled - Product Description 67
Table 132: Stereotaxis Inc Pipeline Products & Ongoing Clinical Trials Overview 68
Table 133: Next Generation Irrigated Magnetic Catheter - Product Status 68
Table 134: Next Generation Irrigated Magnetic Catheter - Product Description 68
Table 135: Strategic Polymer Sciences, Inc Pipeline Products & Ongoing Clinical Trials Overview 69
Table 136: Electroactive Polymer Based Steerable Catheter - Product Status 69
Table 137: Electroactive Polymer Based Steerable Catheter - Product Description 69
Table 138: University of Michigan Pipeline Products & Ongoing Clinical Trials Overview 70
Table 139: Non-Contact Mapping Catheter - Product Status 70
Table 140: Non-Contact Mapping Catheter - Product Description 70
Table 141: University of Rochester Pipeline Products & Ongoing Clinical Trials Overview 71
Table 142: RF Ablation Catheter - Product Status 71
Table 143: RF Ablation Catheter - Product Description 71
Table 144: University of Texas Medical Branch at Galveston Pipeline Products & Ongoing Clinical Trials Overview 72
Table 145: Ablation Catheter - Product Status 72
Table 146: Ablation Catheter - Product Description 72
Table 147: Vanderbilt University Pipeline Products & Ongoing Clinical Trials Overview 73
Table 148: Temperature Controlled Catheter - Product Status 73
Table 149: Temperature Controlled Catheter - Product Description 73
Table 150: Vimecon GmbH Pipeline Products & Ongoing Clinical Trials Overview 74
Table 151: Vimecon Catheter - Product Status 74
Table 152: Vimecon Catheter - Product Description 74
Table 153: Vivonics, Inc. Pipeline Products & Ongoing Clinical Trials Overview 75
Table 154: Catheter Guidance System - Product Status 75
Table 155: Catheter Guidance System - Product Description 75
Table 156: Voyage Medical (Inactive) Pipeline Products & Ongoing Clinical Trials Overview 76
Table 157: IRIS Ablation System - Product Status 76
Table 158: IRIS Ablation System - Product Description 76
Table 159: Glossary 127
1.2 List of Figures
Figure 1: Electrophysiology Ablation Catheters - Pipeline Products by Stage of Development 10
Figure 2: Electrophysiology Ablation Catheters - Pipeline Products by Segment 11
Figure 3: Electrophysiology Ablation Catheters - Pipeline Products by Territory 12
Figure 4: Electrophysiology Ablation Catheters - Pipeline Products by Regulatory Path 13
Figure 5: Electrophysiology Ablation Catheters - Pipeline Products by Estimated Approval Date 14
Figure 6: Electrophysiology Ablation Catheters - Ongoing Clinical Trials 15
